Hong Kong Pharma Digital Technology (NASDAQ:HKPD) Stock Price Down 0% – What’s Next?

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPDGet Free Report) shares dropped 0% on Thursday . The stock traded as low as $0.7671 and last traded at $0.7970. Approximately 14,705 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 33,178 shares. The stock had previously closed at $0.7971.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Hong Kong Pharma Digital Technology in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Read Our Latest Stock Report on HKPD

Hong Kong Pharma Digital Technology Price Performance

The stock has a 50-day moving average price of $0.88 and a two-hundred day moving average price of $1.14.

About Hong Kong Pharma Digital Technology

(Get Free Report)

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.

Recommended Stories

Receive News & Ratings for Hong Kong Pharma Digital Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hong Kong Pharma Digital Technology and related companies with MarketBeat.com's FREE daily email newsletter.